Skip to main content
Assertio Holdings, Inc. logo

Assertio Holdings, Inc. — Investor Relations & Filings

Ticker · ASRT ISIN · US2499081048 US Manufacturing
Open in API
Filings indexed 393 across all filing types
Latest filing 2026-05-18 M&A Activity
Country US United States of America
Listing US ASRT

About Assertio Holdings, Inc.

https://www.assertiotx.com/

Assertio Holdings, Inc. is a commercial pharmaceutical company that provides differentiated products to patients. The company focuses on building and managing a portfolio of branded prescription products. Its primary therapeutic areas of focus include neurology, orphan diseases, and other specialty fields. Assertio's strategy involves acquiring and commercializing established pharmaceutical assets to serve patient needs in its targeted markets.

Recent filings

Filing Released Lang Actions
FORM 8-K
M&A Activity Classification · 98% confidence The document is a United States SEC Form 8-K current report filed pursuant to the Securities Exchange Act of 1934. Item 8.01 discloses the entry into an Agreement and Plan of Merger and the commencement of a cash tender offer for all outstanding shares of common stock, followed by a subsequent merger. This is an announcement and documentation of a takeover bid/merger transaction. Under the provided classification scheme, this falls squarely under “M&A Activity” (Code: TAR) for announcements related to merger proposals or takeover bids.
2026-05-18 English
8-K - Assertio Holdings, Inc. (0001808665) (Filer)
M&A Activity Classification · 85% confidence The document is a Form 8-K Current Report filed with the SEC, detailing the entry into a material definitive merger agreement, support agreements, and a convertible notes tender offer – all elements of a merger and acquisition transaction announcement. It is not a full annual or interim report, nor a proxy or tender‐offer statement form (e.g., DEFM14A or SC 14D9), so the appropriate classification is a general M&A Activity announcement (Code: TAR).
2026-05-13 English
10-Q - Assertio Holdings, Inc. (0001808665) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-08 English
8-K - Assertio Holdings, Inc. (0001808665) (Filer)
M&A Activity Classification · 85% confidence The document is a Form 8-K current report under the Exchange Act. It falls under Item 7.01 (Regulation FD Disclosure) and discloses an extension of the deadline to commence a previously announced tender offer under an Amended and Restated Merger Agreement. This is clearly related to a takeover/tender‐offer aspect of an M&A transaction, rather than a simple regulatory filing or capital update. Therefore it is best classified in the M&A Activity category.
2026-05-08 English
8-K - Assertio Holdings, Inc. (0001808665) (Filer)
Declaration of Voting Results & Voting Rights Announcements Classification · 85% confidence The document is a Form 8-K (“Current Report”) reporting the results of the 2026 Annual Meeting of Stockholders, specifically under Item 5.07 providing the official voting tallies on director elections, plan amendment, executive compensation advisory vote, and auditor ratification. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (Code: DVA).
2026-05-07 English
8-K - Assertio Holdings, Inc. (0001808665) (Filer)
M&A Activity Classification · 90% confidence The document is a Form 8-K current report under the Securities Exchange Act of 1934. It primarily furnishes a press release (Exhibit 99.1) announcing the extension of the deadline to commence a previously announced tender offer in connection with an Amended and Restated Agreement and Plan of Merger. This is an announcement relating to a merger proposal and takeover bid – matching the “M&A Activity” category (Code: TAR).
2026-05-05 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.